These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 23804521

  • 1. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S, Jordanov SH, Mitkova AV, Chalakov IJ, Melnicharov MB, Kunev KV, Mitev VI, Kaneva RP, Goranova TE.
    Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
    [Abstract] [Full Text] [Related]

  • 2. CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues.
    Kupčinskaitė-Noreikienė R, Skiecevičienė J, Jonaitis L, Ugenskienė R, Kupčinskas J, Markelis R, Baltrėnas V, Sakavičius L, Semakina I, Grižas S, Juozaitytė E.
    Medicina (Kaunas); 2013 Aug; 49(8):361-6. PubMed ID: 24509146
    [Abstract] [Full Text] [Related]

  • 3. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D, Pongsapich W, Heinrich U, Mann S, Mann WJ, Brieger J.
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [Abstract] [Full Text] [Related]

  • 4. Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.
    Kupcinskaite-Noreikiene R, Ugenskiene R, Noreika A, Rudzianskas V, Gedminaite J, Skieceviciene J, Juozaityte E.
    BMC Cancer; 2016 Jan 26; 16():40. PubMed ID: 26810771
    [Abstract] [Full Text] [Related]

  • 5. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
    Psofaki V, Kalogera C, Tzambouras N, Stephanou D, Tsianos E, Seferiadis K, Kolios G.
    World J Gastroenterol; 2010 Jul 28; 16(28):3553-60. PubMed ID: 20653064
    [Abstract] [Full Text] [Related]

  • 6. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma.
    Wang J, Sasco AJ, Fu C, Xue H, Guo G, Hua Z, Zhou Q, Jiang Q, Xu B.
    Cancer Epidemiol Biomarkers Prev; 2008 Jan 28; 17(1):118-25. PubMed ID: 18199718
    [Abstract] [Full Text] [Related]

  • 7. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
    Melchers LJ, Clausen MJ, Mastik MF, Slagter-Menkema L, van der Wal JE, Wisman GB, Roodenburg JL, Schuuring E.
    Epigenetics; 2015 Jan 28; 10(9):850-60. PubMed ID: 26213212
    [Abstract] [Full Text] [Related]

  • 8. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
    Banzai C, Nishino K, Quan J, Yoshihara K, Sekine M, Yahata T, Tanaka K, Gynecological Cancer Registry of Niigata.
    Int J Clin Oncol; 2014 Feb 28; 19(1):127-32. PubMed ID: 23494221
    [Abstract] [Full Text] [Related]

  • 9. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
    Furlan D, Carnevali I, Marcomini B, Cerutti R, Dainese E, Capella C, Riva C.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3329-36. PubMed ID: 16740754
    [Abstract] [Full Text] [Related]

  • 10. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
    de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, van den Brandt PA, de Bruïne AP, van Engeland M.
    Ann Oncol; 2009 Jul 01; 20(7):1216-22. PubMed ID: 19164452
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
    Su Y, Yin L, Liu R, Sheng J, Yang M, Wang Y, Pan E, Guo W, Pu Y, Zhang J, Liang G.
    Med Oncol; 2014 Feb 01; 31(2):784. PubMed ID: 24366688
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
    Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, Point D, Tsourouflis G, Sastre-Garau X.
    J Oral Pathol Med; 2011 Mar 01; 40(3):218-26. PubMed ID: 21029181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.